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The prion protein (PrP) resides in lipid rafts in vivo,
and lipidsmodulatemisfolding of the protein to infec-
tious isoforms. Here we demonstrate that binding of
recombinant PrP to model raft membranes requires
the presence of ganglioside GM1. A combination of
liquid- and solid-state NMR revealed the binding
sites of PrP to the saccharide head group of GM1.
The binding epitope for GM1 was mapped to the
folded C-terminal domain of PrP, and docking simu-
lations identified key residues in the C-terminal
region of helix C and the loop between strand S2
and helix B. Crucially, this region of PrP is linked to
prion resistance in vivo, and structural changes
caused by lipid binding in this region may explain
the requirement for lipids in the generation of infec-
tious prions in vitro.
INTRODUCTION
Prion diseases are fatal neurological disorders characterized by
the structural conversion of the normal, a-helical, cellular prion
protein (PrPC) to a b sheet-rich aggregated state. PrPC is a glyco-
sylphosphatidylinositol (GPI)-anchored membrane protein ex-
pressed predominantly in the brain (Stahl et al., 1987). Like
most GPI-anchored proteins, PrP is trafficked into specialized
lipid raft domains that are rich in cholesterol and sphingolipids
(Vey et al., 1996). Numerous roles have been ascribed to lipid
rafts, and these roles include organization and compartmentali-
zation of signaling molecules. Lipid rafts have also been sug-
gested to provide vehicles for endocytosis and trafficking of
signaling components to and from the cell membrane. The
emerging view of cellular membranes and signalingmechanisms
indicates that the signaling molecules are arranged in stable and
sometimes preformed complexes at the cell surface (Allen et al.,
2007). The study of protein interactions with their natural cellular1422 Chemistry & Biology 18, 1422–1431, November 23, 2011 ª2011neighbors, be it other proteins, lipids, or carbohydrates, is impor-
tant to identify those associations relevant for their normal func-
tion and, in the case of the prion protein, may also shed some
light on the disease mechanism. In this context, the study of
PrP-lipid interactions is of particular interest, since lipids are
also one of the few constituents that appear necessary to allow
the generation of infectious prions in vitro (Deleault et al., 2007;
Wang et al., 2010).
In a recent study, we have shown that the majority of PrP in
neuronal cell lines is found at the cell surface in lipid raft
domains rich in ganglioside GM1 (Sanghera et al., 2008).
Gangliosides are a family of glycosphingolipids that are abun-
dant in the brain, representing up to 10% of a neuron’s total
lipid content, and are a major component of lipid rafts (Ledeen,
1978). These molecules appear to play a crucial role in neuronal
differentiation and function (Ferrari and Greene, 1998; Ledeen
et al., 1998). In addition, gangliosides such as GM1 promote
neuroregeneration when added exogenously to damaged
neurons, which has led to the investigation of the therapeutic
potential of these compounds in neurological disorders
(Mocchetti, 2005). Gangliosides may also play a more direct
role in neurological diseases. For example, GM1-gangliosidosis
is a lysosomal storage disease that is characterized by the
accumulation of GM1 in the brain and the formation of membra-
nous cytoplasmic bodies in neurons (Tessitore et al., 2004). In
Alzheimer’s disease, the concentration of GM1 in the cerebro-
spinal fluid of patients is significantly higher compared to
aged-matched controls, leading to the proposal that ganglio-
sides including GM1 are involved in disease pathogenesis
(Blennow et al., 1991). In the present study, we describe the
binding of full-length, recombinant prion protein, PrP(23–231),
to lipid systems, including model raft membranes. We have
identified a specific interaction with GM1, the main gan-
glioside in neuronal membranes, and have employed a compre-
hensive range of spectroscopic analyses to characterize this
interaction. We present a molecular model of the PrP-GM1
interaction, and the likely location of the binding of GM1 on
PrP points to a role for the complex in modulating prion protein
misfolding.Elsevier Ltd All rights reserved
Table 1. Apparent Dissociation Constant (KDapp) of PrP(23–231)
and Truncated Domain PrP(90–231) to GM1 in Vesicles or
Micelles and to GM1os
Lipid System
PrP(23–231) PrP(90–231)
KDapp / mM
GM1-raft vesicles,a pH 5 368 ± 8 78 ± 5
GM1-raft vesicles, pH 5 and saltb 605 ± 77 —
GM1-raft vesicles,a pH 7 129 ± 14 92 ± 3
GM1 micelles, pH 5 12 ± 3 3.9 ± 0.8
GM1 micelles, pH 7 8 ± 1 2.5 ± 0.6
GM1os, pH 5 293 ± 15 __
GM1os, pH 7 239 ± 13 __
KDapp was calculated using a simple two-state binding model.
aGM1-enriched rafts containing DPPC/Chol/SM/GM1 at a molar ratio of
10:6:4:5.
bGM1-raft vesicles in the presence of 200 mM NaCl.
Figure 1. Binding of PrP(23–231) to Different Lipids. The blue shift
(Dl) of the fluorescence maximum for PrP(23–231) in the presence
of lipid membranes relative to PrP(23–231) in solution
(A) Binding of PrP(23–231) to model raft membranes composed of DPPC,
cholesterol (chol), and sphingomyelin (SM) (molar ratio of 5:3:2) at pH 5 (open
circles) and GM1-enriched rafts containing DPPC/chol/SM/GM1 (molar ratio
10:6:4:5) at pH 7 (triangles), at pH 5 (squares), and in the presence of 200 mM
NaCl at pH 5 (filled circles).
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GM1 Is Required for Binding of PrP(23–231) to Model
Raft Membranes
Binding of proteins to lipid vesicles is accompanied by a blue
shift of intrinsic tryptophan fluorescence from the protein
(Kazlauskaite et al., 2003, Sanghera and Pinheiro, 2002,
Schroeder et al., 1994). Here, we use this property to investigate
the binding of full length prion protein, PrP(23–231), to model
lipid membranes. Studies were undertaken at pH 7 and 5, to
model the environment of the plasma membrane and in endo-
somes, respectively, two subcellular compartments that are
involved in the normal cell biology of PrPC and are also impli-
cated in prion pathogenesis (Borchelt et al., 1992; Caughey
and Raymond, 1991; Caughey et al., 1991). The fluorescence
spectra of PrP(23–231) in solution at pH 5 and 7 have amaximum
intensity at 350 nm (lmax), which indicates that the Trp residues
are predominately solvent exposed. The binding of PrP(23–231)
to model raft membranes composed of 1,2-dipalmitoyl-sn-glyc-
ero-3-phosphocholine (DPPC), cholesterol, and sphingomyelin
(DPPC/chol/SM) with and without GM1 was investigated. We
observed binding of PrP(23–231) to model raft membranes en-
riched with GM1, and this binding resulted in a maximum shift
in the lmax of 11 nm (Figure 1A), similar to that observed upon
binding of PrP(23–231) to anionic 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phospho-rac-(1-glycerol) (POPG) membranes (Figure 1B).
No significant binding was noted with model raft membranes
lacking GM1 at either pH 7 (data not shown) or 5 (Figure 1A) or
with zwitterionic lipid membranes of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) (Figure 1B). Binding of
PrP(23–231) to GM1-enriched model raft membranes was
reduced in the presence of 200 mM NaCl (Figure 1A), from an
apparent dissociation constant KDapp of 368 ± 8 mM without
salt to 605 ± 77 mM in the presence of NaCl (Table 1). Collectively,
these results show that the binding of PrP(23–231) to model(B) Binding of PrP(23–231) to single lipid membranes of POPG at pH 5 (circles)
and pH 7 (triangles) and POPC at pH 7 (squares).
(C) Binding of PrP(23–231) to GM1 micelles at pH 7 (filled circles) and with
added 200 mM NaCl at pH 7 (open circles) and pH 5 (triangles).
1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1423
Figure 2. Structural Changes of PrP(23–231) at pH 7.0
(A) Attenuated total reflection Fourier transform infrared and (B) circular
dichroism spectra of PrP(23–231) alone (dashed line), with GM1 micelles
(continuous line), and with POPG vesicles (dash-dotted line).
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part of this interaction is electrostatic.
GM1 micelles were employed to investigate further the inter-
action between PrP(23–231) and GM1, which revealed a similar
binding to GM1 in vesicles with a maximum blue shift of 15 nm
(Figure 1C). Measurements in the presence of 200 mM NaCl
resulted in an analogous binding curve (Figure 1C); incremental
addition of NaCl (up to 2.2 M) to PrP(23–231)-GM1 complexes
at binding saturation did not cause a shift in the lmax of fluores-
cence from the 335 nm characteristic of the bound state (data
not shown). These results indicate that PrP(23–231) is not
released from GM1 micelles upon addition of salt, suggesting
that the nature of the PrP(23–231)-GM1 interaction is not purely
electrostatic.
Lipid binding curves were analyzed with a simple two-state
model, and apparent dissociation constants (KDapp) for PrP(23–
231) binding to various lipid systems were compared with those
for the N-terminally truncated protein, PrP(90–231), where avail-
able (Table 1). The KDapp values show enhanced binding of
N-terminally truncated protein to GM1, either in vesicles or
micelles, compared to full-length prion protein, PrP(23–231).
The binding of both proteins is stronger with micelles compared
with vesicles, and PrP(23–231) shows higher pH dependence,
having lower dissociation constants at neutral pH than at pH 5.
In contrast, the dissociation constant for PrP(90–231) does not
show a significant variation between pH 7 and 5.
Binding of GM1 to PrP(23–231) Induces Subtle
Structural Changes in the Protein
The structure of PrP(23–231) bound toGM1micelles was probed
by circular dichroism (CD) and Fourier transform infrared (FTIR)
spectroscopy. The broad amide I band in the FTIR spectra of
PrP(23–231) in solution was centered around 1660 cm1, indi-
cating the presence of a-helical structure (Figure 2A). The CD
spectrum also shows typical features of a protein containing
a large amount of a-helical structure with well-defined minima
at 208 and 222 nm (Figure 2B). Both CD and FTIR spectra of
PrP(23–231) were found to be identical at pH 5 and 7. The CD
spectrum of PrP bound to GM1micelles shows a small decrease
in signal intensity at 222 nm and a more pronounced decrease in
intensity at 208 nm. These changes are consistent with a reduc-
tion in the amount of random coil structure in the protein rather
than loss of a-helical structure. By comparison, the CD spectrum
of PrP(23–231) bound to POPG membranes shows a single
broad band around 220 nm, clearly indicating that the protein
underwent a significant structural rearrangement to b sheet
structure caused by POPG. The FTIR spectrum of PrP bound
to GM1 micelles shows a broad amide I band centered around
1660 cm1, indicating the presence of a-helical structure; and
the appearance of a shoulder at 1630 cm1 suggests the addi-
tional presence of more-ordered, b sheet structure (Figure 2A).
In contrast, the amide I band in the FTIR spectra for PrP(23–
231) associated with POPG vesicles shows a broad band
centered around 1650 cm1 with a well-defined shoulder around
1630 cm1, indicating the presence of b sheet structure (Fig-
ure 2A). As anticipated from the fluorescence binding
data, POPC alone does not induce any measurable changes in
the protein CD spectrum (data not shown). In summary, the
interaction of PrP(23–231) with POPG dramatically alters the1424 Chemistry & Biology 18, 1422–1431, November 23, 2011 ª2011structure of the protein to a b-sheet-containing conformation,
whereas the interaction with GM1 produces more-subtle
changes in the structure of PrP(23–231), consistent with reten-
tion of the folded a-helical C-terminal domain and increased
structural definition of the unstructured N-terminal tail of
PrP(23–231).Elsevier Ltd All rights reserved
Figure 3. 13C Cross-Polarization/Magic Angle Spinning Solid-State NMR Spectra of Hydrated Lipid Membranes
(A) POPC/GM1 (4:1) with PrP(23–231), (B) POPC/GM1 (4:1), and (C) POPC. The molecular structure shows the carbon numbering scheme for GM1 according to
Yagi-Utsumi et al. (2010).
Chemistry & Biology
Prion Protein Binds to GM1 in Lipid RaftsPrP Binds to the GM1 Saccharide Head Group
and Inserts into the Lipid Bilayer
The interaction between PrP(23–231) and GM1 in mixed lipid
membranes containing POPC/GM1 4:1 was investigated by
13C cross-polarization/magic angle spinning (CP-MAS) solid-
state NMR (ssNMR). Spectra with and without PrP(23–231) are
shown in Figure 3, and distinct spectral regions are enlarged in
Figure 4. Resonances arising from GM1 were assigned by
comparison to 13C assignments in solution (Yagi-Utsumi et al.,
2010; Pukin et al., 2008). Peaks at low-field (0–40 ppm) arise
predominantly from hydrocarbon methylene and methyl groups
of both POPC and GM1, as well as from the N-acetyl methyl
groups on rings III (C-8, 25.6 ppm) and A (C-11, 22.4 ppm). These
resonances (highlighted) are present in the spectrum of GM1/
POPC (Figure 4D, middle spectrum) but are absent from theChemistry & Biology 18, 1422–143spectrum acquired in the presence of PrP(23–231) (Figure 4D,
top spectrum), which is consistent with protein binding to these
chemical groups, thereby increasingmolecular rigidity and longi-
tudinal relaxation time, T1. To verify this interpretation, CP-MAS
experiments were carried out with the interpulse delay increased
from 3.5 to 20 s, which led to marked recovery of signal intensity
from the III-8 and A-11 resonances (data not shown).
The majority of GM1 head group resonances fall within spec-
tral region from 50 to 85 ppm (Figure 4C), as do resonances from
the sphingosine backbone carbons, C-1 and C-2. Spectral
changes on addition of PrP(23–231) include loss of intensity in
resonances A-7 (66.6 ppm) and A-9 (65.0 ppm), as well as A-8
(68.3 ppm). An upfield shift in resonance II-4 at the glycosidic
bond with ring III, from 77.2 to 77.4 ppm, points to involvement
of ring II in the binding epitope. A small downfield shift in A-61, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1425
Figure 4. Enlarged Spectral Regions from the 13C Magic Angle Spinning NMR Spectra
The spectra show resonance assignments and highlight changes in spectral intensity and chemical shifts for (A) the carbonyl region, (B) the HC=CH region, (C) the
oligosaccharide region, and (D) the hydrocarbon chain and N-acetyl methyl groups for POPC/GM1/PrP(23–231) (top spectrum), POPC/GM1 4:1 (middle
spectrum), and POPC (bottom spectrum).
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to 71.1 ppm. Figure 4A shows the carbonyl spectral region,
where signals corresponding to the N-acetyl carbonyls, A-10
and III-7 (175–176 ppm), are lost upon PrP(23–231) binding while
the chemical shift and intensity of the A-1 resonance are unaf-
fected. This confirms the involvement of both N-acetyl amino
groups in the prion-binding epitope, which appears to comprise
the N-acetyl moieties of rings III and A and the propane-triol side
chain of ring A and to affect C-4 from ring II. Conversely, the
peaks in the spectral region around 100 ppm arise from carbons
I-1, II-1, III-1, IV-1, and A-2 and remain relatively unaffected by
the binding of PrP(23–231).
A significant shift in resonances of the lipid double bond
between C-4 and C-5 suggests insertion of PrP(23–231) into
the lipid-water interface. Comparison of the 13C MAS NMR
spectra of GM1 (Figure 4B) in the absence (middle spectrum)
and in the presence of PrP (top spectrum) shows a downfield
shift in C-5 from 133.9 to 133.3 and a concomitant upfield shift
in C-4 from 128.9 to 129.9 upon binding of PrP. Furthermore,
an increase in spectral intensity of the POPC chain resonances
reflects improved CP efficiency and increased order in the lipid1426 Chemistry & Biology 18, 1422–1431, November 23, 2011 ª2011chain. Thus, these data show that the saccharide head group
of GM1 binds directly to PrP(23–231) and that the protein inserts
into the lipid bilayer, stabilizing the lipid chains.
Liquid-State NMR Confirms the PrP Binding Epitope
on GM1
To confirm that the binding site of PrP(23–231) to GM1 predicted
by ssNMR was the same in solution, we investigated the of
binding PrP(23–231) to the GM1 oligosaccharide (GM1os) in
solution. Initially, the interaction was followed by fluorescence
titration measurements (Figures 5A and 5B). The apparent KD
(Table 1) suggests that PrP(23–231) has weaker affinity for
GM1os than for the whole GM1 molecule. In contrast to the
binding of PrP(23–231) to GM1, the association of PrP(23–231)
with GM1os had no effect on the CD spectrum of the protein (Fig-
ure 5C). These data confirm a direct association between PrP
and GM1os but suggest that the lipid chains of GM1 are required
to mediate structural changes in PrP.
The binding epitope for PrP(23–231) on GM1os was investi-
gated by means of solution-phase NMR. 1H NMR and one-
dimensional saturation transfer difference (STD) NMR spectraElsevier Ltd All rights reserved
Figure 5. Binding of GM1os to PrP
(A) Typical quenching spectra of PrP(23–231) with increasing concentrations
of GM1os (continuous lines; in the direction of the arrow) compared to PrP(23–
231) alone (dashed line).
(B) Changes inmaximumfluorescence intensity plotted as a function of GM1os
concentration for PrP(23–231) (triangles) and PrP(23–110) (circles) at pH 5.0
(filled symbols) and pH 7.0 (open symbols). The data are fitted to a simple two-
state model.
(C) Circular dichroism spectra of PrP(23–231) alone at pH 5.0 (dashed line) and
with increasing concentrations of GM1os (45 mM to 2 mM; black lines).
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Chemistry & Biology 18, 1422–143of GM1os bound to PrP(23–231) are shown in Figure 6. NMR
assignments for protons of GM1os have been reported previ-
ously (Ong and Yu, 1986). Protons that interact strongly with the
protein binding site produce large signals in the STD-NMR
spectra and show that the strongest interaction between
GM1os and PrP(23–231) is around ring A, with the largest STD
signals along the propane-triol side chain of ring A. The two
methyl signals of theN-acetyl groups of ring Aand III also indicate
of a strong interaction. The NMR data suggest that the binding
epitope on GM1os is located in the center of the molecule.
Ring A seems to be the most important part of the molecule
for the interaction with the protein. These data allowed us to
develop a molecular schematic for the recognition of PrP(23–
231) as shown in Figure 6C, and the data confirm that the epitope
in solution is the same as that determined by ssNMR.
GM1 Binds to PrP(23–231) in the Vicinity
of the C Terminus
To identify the GM1os binding sites on the protein, GM1 titration
experiments were performed with an N-terminal fragment of
PrP comprising amino acids 23–110. Compared to the binding
of full-length PrP to GM1os, the binding of the N-terminal
domain to GM1os was significantly reduced (Figure 5B), sug-
gesting that the major binding site(s) for GM1 is present on
the structured C-terminal domain of the protein. In support of
this conclusion, we observed binding of N-terminally truncated
protein, PrP(90231), to all GM1-containing lipid systems
studied (Table 1).
Docking simulations were used to investigate the region of PrP
to which the GM1 saccharide binds. The docking of GM1os
generated a binding site between the C-terminal end of helix C
and the loop between b strand S2 and helix B of PrP (Figure 7A),
and the proposed model of PrP/GM1 complex is consistent with
results from both solution-phase and ssNMR experiments. In our
model, Ser222 is located at the center of the binding site (Fig-
ure 7D) and may interact with the propane-triol side chain and
the carboxyl group of ring A. The propane-triol side chain of
ring A inserts into a pocket formed between Ser222 and
Asn170, allowing backbone atoms of the loop between strand
S2 and helix B to participate in additional hydrogen bonding
with the propane-triol group. GM1 hydrogen atoms predicted
to be involved in binding by solution-phase NMR are located
close to side chain atoms of Val166 or Tyr225. The N-acetyl
groups of ring A and ring III are proposed to be located near
Asn170 and Gln219, respectively. The docking simulations re-
vealed interactions with rings I and IV of the GM1 saccharide,
which STD and ssNMR spectra suggested were not involved in
binding to PrP. This may be because docking modes with
maximum interactions or the lowest docking energy are always
favored. However, molecules fluctuate in the aqueous mem-
brane interface, and although the present model shows interac-
tion between PrP and rings I and IV of GM1os, it may represent
a static docking model, which suggests that these regions fluc-
tuate and may not bind tightly to PrP.
DISCUSSION
The association of PrPwithmembranes appears to play a central
role in its biology (Caughey et al., 2009; Pinheiro, 2006). In the1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1427
Figure 6. 1H-NMR Spectrum of GM1os in
Association with PrP(23–231) at pH 5.0
(A) One-dimensional spectrum of GM1os bound to
PrP(23–231) in D2O showing all resonances.
(B) Saturation transfer difference (STD) NMR
spectrum of GM1os bound to PrP(23–231).
Protons making close contact with the protein
show significant enhancement of their reso-
nances, and the signal intensity is proportional to
the strength of binding.
(C) Schematic of GM1os with atoms making
contact with the protein highlighted. Weak inter-
actions aremarked in green, whereasmedium and
strong interactions are shown in yellow and red,
respectively. Protons showing no interactions in
the STD-NMR spectrum are unmarked and/or not
plotted.
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protein PrP(23–231) to lipid membranes. We show that PrP(23–
231) binds with high affinity to anionic lipid membranes but
does not interact with zwitterionic membranes (Figure 1B);
these properties are similar to the lipid binding properties re-
ported for the truncated protein (Kazlauskaite et al., 2003; San-
ghera and Pinheiro, 2002). Our results are consistent with those
of other studies of the binding of full-length PrP to anionic
membranes (Morillas et al., 1999). In contrast, the binding of
PrP(23–231) to model raft membranes, DDPC/chol/SM, is
different from that reported for N-terminally truncated PrP.
Whereas PrP(90–231) was found to bind to DPPC/chol/SM vesi-
cles at pH 7 but not at pH 5 (Sanghera and Pinheiro, 2002),
PrP(23–231) does not bind to these membranes. Binding of
full-length PrP to raft membranes was observed only in the pres-
ence of GM1 (Figure 1A), suggesting a direct interaction between
PrP and GM1.
To decipher the molecular details of the binding of PrP to GM1
lipid, we measured the interaction of PrP(23–231) with GM1 in
micelles and lipid bilayers (vesicles) and compared with the
binding of the protein to the GM1 oligo saccharide, GM1os.1428 Chemistry & Biology 18, 1422–1431, November 23, 2011 ª2011 Elsevier Ltd All rights rePrP(23231) binds to GM1 in vesicles
or micelles and to GM1os with appar-
ent KD values in the micromolar range
(Table 1), indicating a significant interac-
tion with the saccharide moiety. Consid-
ering that PrP(23231) has a high net
positive charge (+9 and +18 at pH 7 and
5, respectively), we anticipated an inter-
action driven by electrostatic forces
between positively charged amino acids
and negatively charged groups of
GM1. However, no binding was ob-
served between the positively charged
N-terminal domain of PrP(23110) (+10
and +15 at pH 7 and 5, respectively) and
GM1os (Figure 5B). Together, these
results strongly suggest that the associa-
tion between PrP and GM1 occurs
through a more specific binding than apurely electrostatic interaction. In previous studies, we have
shown that binding of PrP(90–231) to negatively charged lipid
membranes involves both electrostatic and hydrophobic inter-
actions (Sanghera and Pinheiro, 2002). Since GM1 micelles
cannot be dissociated from PrP(23–231) by salt, and competi-
tion-binding measurements in the presence of salt had little
effect (Figure 1C), hydrophobic forces are clearly involved in
the binding of PrP(23–231) to GM1. This interpretation is further
supported by the experiments with GM1 in raft membranes,
which show binding of PrP(23–231) to GM1 in the presence of
200 mM salt, although binding is weaker than in the absence
of salt (Figure 1A, Table 1).
Interestingly, the association of PrP with GM1 results in subtle
structural changes to the protein, whereas the association with
GM1os does not. The binding sites for PrP on GM1 and
GM1os appear the same, since NMR indicates common
changes in resonances upon binding of PrP. Instead, there
appears to be a role for the lipid chains in modulating the struc-
ture of PrP in the complex with GM1. The ssNMR results suggest
that the sphingosine moiety at the membrane interface may be
critical for this effect (Figure 4B). The broader amide I band inserved
Figure 7. Model of the PrP/GM1os complex
(A) Ribbon diagram of the structure of the PrP globular domain (green) showing
a helices HA, HB, and HC and b sheet strands S1 and S2. The location of the
glycosylphosphatidylinositol lipid anchor is highlighted schematically in black.
GM1os, shown in stick representation (red), binds to the region between the
C-terminal end of helix C and the loop between strand S2 and helix B.
(B) Same as (A) but PrP is drawn in surface representation.
(C) Same as (B) but the orientation of this panel is a 90 rotation about the
vertical axis of (B).
(D) The putative binding site of GM1os on PrP. The region colored in orange
represents the loop region between strand S2 and helix B, and the region in
blue represents the C-terminal end of helix C. The thin red line represents
GM1os. All panels are rendered by means of PyMOL (DeLano and Lam, 2005).
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change in the CD spectrum (Figure 2) are likely to be associated
with ordering of the random coil tail of the protein at the
membrane interface. These results are in line with our previous
findings, which showed that raft membranes preserve the native
a-helical structure of the truncated folded domain of PrP (4). This
interpretation is further supported by electron microscopy of PrP
bound to vesicles containing GM1, where the protein appears to
be smoothly bound to the vesicle surface (data not shown). In
stark contrast, the binding of PrP to POPG membranes induces
a conformational change to a b sheet structure and promotes the
formation of protein aggregates at the membrane surface,
similar to the aggregation observed with the truncated protein
(Kazlauskaite et al., 2003).
The predicted binding epitope for GM1 on PrP involves the
loop region between b strand S2 and a helix B and the C-terminal
end of a helix C. This epitope seems reasonable, given the
predominant orientation of PrPC imposed by the tethering to
the cell surface via the GPI anchor (Figure 7A). In this orientation,
the PrP binding epitope would be accessible to GM1 molecules
in the membrane. The proposed binding of GM1os to the loop
region between strand S2 and helix B of PrP is especially perti-Chemistry & Biology 18, 1422–143nent since this region strongly influences prion susceptibility
(Belt et al., 1995; Westaway et al., 1994). A recent molecular
dynamics simulation study analyzed most known disease-linked
mutations in the prion protein and revealed that the S2-helix B
and helix B-helix C regions are the most affected in terms of
structure and stability (Rossetti et al., 2011), supporting their
crucial role in prion conversion. The key residue whose position
varied as a result of pathogenic mutations was Tyr173 (sheep
numbering), and in addition, the presence of arginine instead
of glutamine at codon 171 in the S2-helix B loop of sheep prion
protein has been shown to confer resistance to scrapie. Although
the mechanism by which Arg171 interferes with prion propaga-
tion is unknown, our recent in vitro folding study of murine
recombinant PrP with the Gln167Arg mutation (equivalent to
codon 171 in sheep) showed that the mutant protein is less
stable than wild-type protein, suggesting that the stability of
PrP-Gln167Arg is not the only factor influencing its disease-
resistant property (Robinson and Pinheiro, 2009). Alternatively,
the introduction of arginine will increase the number of positive
charges in the loop region, which in turn may influence the
binding of PrP to stabilizing cofactors at the membrane surface,
especially in raft domains. Such molecules may include lipid
head groups, and this is currently under further investigation. In
any case, the current data greatly expand our knowledge of
the molecular features of PrP-lipid binding. Understanding
such binding events is of crucial importance in light of recent
reports of the de novo creation of infectious prions in vitro. To
date, all such studies have involved the use of lipids during the
prion protein misfolding process, which suggests that lipids
may be critically important molecules in vivo to mediate prion
protein misfolding during disease Our findings further highlight
that GM1 represents a lipid with which PrP may have regular
and prolonged contact. The selective binding of GM1, possibly
to one of the key areas of PrP directing susceptibility of individ-
uals to prion disease, may be highly significant.
In summary, we report the selective binding of PrP(23–231) to
the major neuronal ganglioside, GM1, and the atomic details of
this interaction are revealed by NMR and molecular modeling.
The findings are highly pertinent given the colocalization of
PrPC and GM1 in neuronal cells (Mattei et al., 2002, Sanghera
et al., 2008). GM1 was found to bind to a region of PrP involved
in disease susceptibility. Given the high concentrations of gangli-
osides in neurons and their localization in rafts (Ledeen, 1978),
the association of PrP with GM1 may play a role in modulating
disease susceptibility. In addition, the interaction of GM1 with
PrP may be relevant to the normal function of the prion protein.
Although the function of PrPC is not yet clear, evidence suggests
an involvement in cell signaling and cell recognition processes at
the cellular membrane (Aguzzi et al., 2008), where protein segre-
gation into rafts and lipid-protein interactions are important.
SIGNIFICANCE
Important interactions with lipids feature in normal prion
protein cell biology, prion disease pathogenesis, and during
the misfolding of prion protein to infectious conformations,
but the molecular details of lipid-prion interactions have
previously not been studied. We provide atomic-level detail
of both binding epitopes in the complex formed between1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1429
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Prion Protein Binds to GM1 in Lipid Raftsthe key neuronal ganglioside, GM1, and the prion protein.
We find that the binding epitope of GM1 on PrP involves
amino acids close to the C terminus of the protein and in
regions previously suggested tomodulate prion proteinmis-
folding. Thus, our data suggest ameans by which lipid-prion
protein interactions on the cell surface can mediate protein
function and protein misfolding and hence prion disease
pathogenesis. The data also indicate how lipid-prion protein
interactions could initiate prion protein misfolding by
affecting stability of a helices of PrP, and the molecular
details of the lipid-prion protein complex will allow such
complexes to be targeted by small-molecule inhibitors.
Our data represent a major advance in our understanding
of the interaction of prion protein with lipids.
EXPERIMENTAL PROCEDURES
Expression, Purification, and Refolding of PrP
SHa PrP(23–231) was expressed in E. coli strain BL21* Rosetta.
The recombinant protein accumulated in inclusion bodies within the
cytoplasm. The protocol for the purification of PrP(23–231) was adapted
from Bocharova et al. (2005), and full details are given in the Supplemental
Experimental Procedures available online.
Preparation of Lipid Vesicles and Micelles
Cholesterol, POPC, POPG, and sphingomyelin were purchased from Avanti
Polar Lipids, Inc. (Alabaster, AL). DPPC and GM1 were from Sigma-Aldrich
(Dorset, UK). Single lipid vesicles of POPG or POPC and mixtures of lipid
components of rafts were prepared as described below. Mixed lipid vesicles
containing 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), cholesterol
(chol), and sphingomyelin (SM) at a molar ratio of 5:3:2 represent the chol-
and SM-rich domains in the plasma membrane known as rafts and are here
referred to as ‘‘raft membranes.’’ GM1-enriched raft membranes contain
DPPC/chol/SM/GM1 at the molar ratio 10:6:4:5 in a solution of chloroform/
methanol 80:20 v/v.
Phospholipids in chloroform solutions were dried under a rotary evaporator
or a N2 flow (depending on sample volume). Mixed lipid membranes were
prepared by codissolving the constituent lipids in chloroform or chloroform/
methanol, and a lipid film formed as described above. Lipid vesicles were
prepared by hydrating the dried lipid or lipid mixture with the required buffer
(2 mM MES at pH 7 or 5). After lipid hydration, the resulting multilamellar lipo-
some suspension was sonicated in a bath sonicator until a clear suspension of
small unilamellar vesicles was obtained (typically 6 3 1/2 h periods).
Micelles of GM1were prepared in the required buffers (2mMMESpH 7 or 5).
Typically, a 2 mM GM1 solution was prepared using an aliquot of a stock
of GM1 in methanol (6.4 mM). The critical micelle concentration of GM1 is
108 M (Ohta et al., 2004).
Spectroscopic Measurements
Binding of PrP proteins to vesicles and micelles was studied by fluorescence
spectroscopy at both pH 7 and 5 at 20C by monitoring the shift in lmax of
protein fluorescence upon addition of increasing amounts of lipid. All fluores-
cence spectra were recorded on a Photon Technology International spectro-
fluorimeter. Attenuated total reflection FTIR spectra were recorded at room
temperature on a Vector 22 infrared spectrometer (Bruker) using a germanium
internal reflection element as described previously (Kazlauskaite et al., 2003).
CD spectra were collected at 20C using a 0.1 cm path length quartz cuvette
(Starna brand, Optiglass Ltd., Hainault, UK) in a Jasco J-715 spectropolarim-
eter (Jasco, Great Dunmow, UK). Full details of these procedures are given in
the Supplementary Experimental Procedures.
Nuclear Magnetic Resonance Spectroscopy
Solution-phase NMR spectra were collected for GM1os/PrP(23–231)
complexes containing 0.2 mg PrP(23–231) and a 10-fold excess of GM1os
in 5 mM MES pH 5.0 buffer prepared in D2O. All NMR spectra were acquired1430 Chemistry & Biology 18, 1422–1431, November 23, 2011 ª2011on a Varian INOVA 800 MHz spectrometer equipped with a cryogenically
cooled HCN probe at 25C. All ssNMR) experiments were carried out on a
Varian 400 MHz VNMRS Direct Drive spectrometer equipped with a 4 mm
T3 MAS NMR probe (Varian, Palo Alto, CA). Lipid film containing POPC/
GM1 (molar ratio 4:1) was hydrated in 1 ml of MES buffer pH 5.0 and added
to 500 ml of PrP(23–231) (200 mg) at pH 5.0. The final lipid/protein ratio was
900:1. Lipid/protein sample was freeze-dried, loaded into a NMR tube, and
hydrated. Full details of these procedures are given in the Supplementary
Experimental Procedures.
Molecular Modeling of GM1/PrP Complex
Complex structures of GM1os/PrP were generated with docking simulations
using AutoDock version 3.05 (Morris et al., 1998). In a first step, docking simu-
lations were performed using virtual mini-GM1s, which share a common
substructure with GM1os but lack some functional groups. Using this strategy,
it was possible to search a large region, including the overall surface of PrP, for
a GM1os binding site. Docking modes obtained by docking simulations were
visually inspected to fit to the STD-NMR result. In a second step, we performed
docking simulations using an entire GM1os and a restricted search region
around a putative binding site identified from the first step. The docking simu-
lations resulted in a number of potential complex structures for PrP/GM1os,
from which one complex model was finally selected on the basis of the results
of the STD-NMR experiments and the best fit for the docking modes of virtual
mini-GM1s. Further optimization for the selected dockingmodel and re-adding
hydrogen atoms were performed with Molegro Molecular Viewer (Thomsen
and Christensen, 2006). More details of these procedures are given in the
Supplementary Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and can be found with this article online at doi:10.1016/j.chembiol.2011.
08.016.
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